$CYBN Phase 1 CYB004 study highlights: -Escalating doses of DMT IV infusion over 90 minutes were well-tolerated- -Robust psychedelic effects were produced, and the intensity of effects was related to the rate at which the peak concentration was achieved.- -Deuteration of DMT, as with CYB004, resulted in stronger psychedelic effects at lower plasma concentrations, compared with native DMT.- -These psychedelic effects were rapid in onset when administered as an IV bolus over 5 minutes and persisted for about 40 minutes after the bolus without the need for an extended infusion.- -This short duration of effects has the potential for CYB004 to be a scalable treatment that can be delivered in a shorter period of time compared with longer acting psychedelics.- ir.cybin.com/investors/news/… $BCRX $CROX $TECH $REGN $SPY $VVOS $TSLA $GME $CYTO $AMC $MULN $QQQ $YOSH $BABA $FSR $COIN $FTCH $NVDA $BETS $SOFI $NIO $MMAT $NVOS $HSCS $AFRM $SHOT $CPHI $ATXI $MARA $PLTR $LUNC.X $SNOW $AAPL $AMZN $AULT $CRM $BITF $ASTS $QS $DIS $GOEV $DWAC $CENN $RIVN $AUPH $MSFT

5 Scientifically Proven Truisms About The Amazing Pharmacological Effects Of Psilocybin $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF benzinga.com/markets/penny-s…

$CYBN's CYB003 phase 2 interim data shows MASSIVE reduction in depressive symptoms after just a single dose - a huge improvement from current mental health treatments. Cybin CEO Doug Drysdale @insidepharma calls it "the biggest breakthrough in psychiatric pharmacology in 40 years." Watch the full interview with @TheDalesReport youtube.com/watch?v=op1CjMBy…